Skip to main content
Terug
Watch Compare

INTELLIGENT BIO SOLUTIONS INC.

Datakwaliteit: 100%
INBS
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 2,52
▼ € 0,13 (-4,91%)
Marktkapitalisatie: 5,04 M
Prijs
€ 2,52
Marktkapitalisatie
5,04 M
Dagbereik
€ 2,50 — € 2,65
52-Weeksbereik
€ 2,46 — € 24,90
Volume
26.144
Openen € 2,65
50D / 200D Gem.
€ 4,92
48,82% below
50D / 200D Gem.
€ 10,61
76,24% below

Quick Summary

Belangrijkste Punten

Revenue grew 11,42% annually over 5 years — strong growth
Negative free cash flow of -9,75 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 13,32%

Groei

Revenue Growth (5Y)
11,42%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)-1,90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-153,51%
Onder sectorgemiddelde (-53,41%)
ROIC-101,92%
Net Margin-340,03%
Op. Margin-339,91%

Veiligheid

Debt / Equity
N/A
Current Ratio2,37
Interest Coverage-132,56

Waardering

PE (TTM)
-0,45
Boven sectorgemiddelde (-1,48)
P/B Ratio0,45
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,5 -1,5
P/B 0,5 1,6
ROE % -153,5 -53,4
Net Margin % -340,0 -41,5
Rev Growth 5Y % 11,4 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -1,90% Revenue Growth (3Y) 55,84%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 11,42% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3,32 M Net Income (TTM) -11,29 M
ROE -153,51% ROA -81,57%
Gross Margin 49,83% Operating Margin -339,91%
Net Margin -340,03% Free Cash Flow (TTM) -9,75 M
ROIC -101,92% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,37
Interest Coverage -132,56 Asset Turnover 0,24
Working Capital 7,05 M Tangible Book Value 7,82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,45 Forward P/E N/A
P/B Ratio 0,45 P/S Ratio 1,52
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -193,34%
Market Cap 5,04 M Enterprise Value 4,30 M
Per Share
EPS (Diluted TTM) -7,09 Revenue / Share 1,66
FCF / Share -4,87 OCF / Share -4,69
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 11,15% FCF Conversion 86,33%
SBC-Adj. FCF -10,04 M Growth Momentum -13,32

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3,05 M 3,11 M 1,26 M 437.146,0 1,98 M
Net Income -10,57 M -10,16 M -10,63 M -8,31 M -7,04 M
EPS (Diluted) -2,00 -6,38 -10,58 — —
Gross Profit 1,25 M 1,43 M 326.668,0 — —
Operating Income -10,64 M -10,28 M -12,60 M -8,34 M -5,57 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 970.117,0 974.355,0 814.481,0 — —
Interest Expense 60.890,0 — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,25 M 13,78 M 10,35 M 12,35 M 21,86 M
Total Liabilities 5,44 M 5,60 M 6,67 M 5,81 M 6,85 M
Shareholders' Equity 3,00 M 8,33 M 3,80 M 6,62 M 15,06 M
Total Debt 1,65 M 1,65 M — — —
Cash & Equivalents 1,02 M 6,30 M 1,54 M 8,24 M 12,57 M
Current Assets 4,14 M 8,53 M 3,86 M 10,87 M 18,21 M
Current Liabilities 5,35 M 5,45 M 5,88 M 4,66 M 3,68 M